The Patent Finder

Maintenance fees coming due

Vertex Pharmaceuticals Incorporated

66 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Nov 19, 2026. Unpaid by May 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 9,035,053Processes for Making Compounds Useful as Inhibitors of ATR Kinase
In force
Fee due Nov 19, 2026
Lapses if unpaid May 19, 2027
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceNov 19, 2026May 19, 2027High confidence
US 9,035,072Process of Producing Cycloalkylcarboxamido-Indole Compounds
In force
Fee due Nov 19, 2026
Lapses if unpaid May 19, 2027
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceNov 19, 2026May 19, 2027High confidence
US 9,038,488Systems and Methods for Inline Sampling
In force
Fee due Nov 26, 2026
Lapses if unpaid May 26, 2027
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceNov 26, 2026May 26, 2027High confidence
US 10,301,304Selective Inhibitor of Phosphatidylinositol 3-Kinase-GAMMA
In force
Fee due Nov 28, 2026
Lapses if unpaid May 28, 2027
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceNov 28, 2026May 28, 2027High confidence
US 10,302,602Process of Conducting High Throughput Testing High Performance Liquid Chromatography
In force
Fee due Nov 28, 2026
Lapses if unpaid May 28, 2027
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceNov 28, 2026May 28, 2027High confidence
US 9,045,425Solid Forms of N-[2,4-BIS(1,1-Dimethylethyl)-5-Hydroxyphenyl]-1,4-Dihydro-4-Oxoquinoline-3-Carboxamide
In force
Fee due Dec 2, 2026
Lapses if unpaid Jun 2, 2027
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceDec 2, 2026Jun 2, 2027High confidence
US 9,051,270Pyridone Amides as Modulators of Sodium Channels
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceDec 9, 2026Jun 9, 2027High confidence
US 9,051,303Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL)-N-(1-(2,3-Dihydroxypropyl)-6-Fluoro-2-(1-Hydroxy-2-Methylpropan-2-YL)-1H-LNDOL-5-YL)CYCLOPROPANECARBOXAMIDE
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · Medium confidence
Vertex Pharmaceuticals IncorporatedIn forceDec 9, 2026Jun 9, 2027Medium confidence
US 9,051,319Inhibitors of Influenza Viruses Replication
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · Medium confidence
Vertex Pharmaceuticals IncorporatedIn forceDec 9, 2026Jun 9, 2027Medium confidence
US 9,051,324Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · Medium confidence
Vertex Pharmaceuticals IncorporatedIn forceDec 9, 2026Jun 9, 2027Medium confidence
56 more maintenance fees coming due in the 12 months from Nov 16, 2026 · Pro
10 of 66 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited